Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review
Mitochondrial dysfunction is associated with the etiologies of sensorineural hearing loss, such as age-related hearing loss, noise- and ototoxic drug-induced hearing loss, as well as hearing loss due to mitochondrial gene mutation. Mitochondria are the main sources of reactive oxygen species (ROS) a...
Main Authors: | Chisato Fujimoto, Tatsuya Yamasoba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/8/4/109 |
Similar Items
-
Role of Oxidative Stress and Antioxidants in Acquired Inner Ear Disorders
by: Megumi Kishimoto-Urata, et al.
Published: (2022-07-01) -
Mitochondria-Targeted Antioxidants and Skeletal Muscle Function
by: Sophie C. Broome, et al.
Published: (2018-08-01) -
Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics
by: P. Hemachandra Reddy
Published: (2011-02-01) -
Mitochondria as Targets for Endothelial Protection in COVID-19
by: Boris V. Chernyak, et al.
Published: (2020-11-01) -
Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
by: Benyu Nan, et al.
Published: (2022-01-01)